Control of cardiovascular risk factors in the veterans affairs diabetes trial in advanced type 2 diabetes

William C. Duckworth, Madeline McCarren, Carlos Abraira

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: To present a status report on the Veterans Affairs, Diabetes Trial (VADT), a multisite long-term study examining the effect of glucose control on cardiovascular (CV) complications in older patients with established, poorly controlled type 2 diabetes. Methods: We review the rationale, objectives, and design of the VADT and summarize the baseline data and the results achieved thus far. Results: The main objective of this 20-site, 1,792-patient study is to ascertain whether intensive glucose control can reduce major CV events in patients with difficult-to-control type 2 diabetes. The study design consists of a standard treatment arm and an intensive treatment arm, with a goal of 1.5% difference in hemoglobin A1c values between the two groups. The trial is now in its fifth year, with completion expected in December 2007. The planned glucose separation has been achieved and maintained to this point. Blood pressure and hemoglobin A1c levels have been reduced from baseline values, and established CV risk factors are within recommended ranges. Conclusion: The current results of the VADT show that excellent control of glucose and CV risk factors can be achieved and maintained in the population studied. The results of these interventions on CV outcomes will ultimately have important implications for the clinical care of older patients with advanced type 2 diabetes.

Original languageEnglish
Pages (from-to)85-88
Number of pages4
JournalEndocrine Practice
Volume12
Issue numberSUPPL. 1
StatePublished - Jan 1 2006

Fingerprint

Veterans
Type 2 Diabetes Mellitus
Glucose
Hemoglobins
Patient Care
Blood Pressure
Therapeutics
Population

ASJC Scopus subject areas

  • Endocrinology

Cite this

Control of cardiovascular risk factors in the veterans affairs diabetes trial in advanced type 2 diabetes. / Duckworth, William C.; McCarren, Madeline; Abraira, Carlos.

In: Endocrine Practice, Vol. 12, No. SUPPL. 1, 01.01.2006, p. 85-88.

Research output: Contribution to journalArticle

Duckworth, WC, McCarren, M & Abraira, C 2006, 'Control of cardiovascular risk factors in the veterans affairs diabetes trial in advanced type 2 diabetes', Endocrine Practice, vol. 12, no. SUPPL. 1, pp. 85-88.
Duckworth, William C. ; McCarren, Madeline ; Abraira, Carlos. / Control of cardiovascular risk factors in the veterans affairs diabetes trial in advanced type 2 diabetes. In: Endocrine Practice. 2006 ; Vol. 12, No. SUPPL. 1. pp. 85-88.
@article{63a01c875df6483eaf1b0b23600160ed,
title = "Control of cardiovascular risk factors in the veterans affairs diabetes trial in advanced type 2 diabetes",
abstract = "Objective: To present a status report on the Veterans Affairs, Diabetes Trial (VADT), a multisite long-term study examining the effect of glucose control on cardiovascular (CV) complications in older patients with established, poorly controlled type 2 diabetes. Methods: We review the rationale, objectives, and design of the VADT and summarize the baseline data and the results achieved thus far. Results: The main objective of this 20-site, 1,792-patient study is to ascertain whether intensive glucose control can reduce major CV events in patients with difficult-to-control type 2 diabetes. The study design consists of a standard treatment arm and an intensive treatment arm, with a goal of 1.5{\%} difference in hemoglobin A1c values between the two groups. The trial is now in its fifth year, with completion expected in December 2007. The planned glucose separation has been achieved and maintained to this point. Blood pressure and hemoglobin A1c levels have been reduced from baseline values, and established CV risk factors are within recommended ranges. Conclusion: The current results of the VADT show that excellent control of glucose and CV risk factors can be achieved and maintained in the population studied. The results of these interventions on CV outcomes will ultimately have important implications for the clinical care of older patients with advanced type 2 diabetes.",
author = "Duckworth, {William C.} and Madeline McCarren and Carlos Abraira",
year = "2006",
month = "1",
day = "1",
language = "English",
volume = "12",
pages = "85--88",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Control of cardiovascular risk factors in the veterans affairs diabetes trial in advanced type 2 diabetes

AU - Duckworth, William C.

AU - McCarren, Madeline

AU - Abraira, Carlos

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Objective: To present a status report on the Veterans Affairs, Diabetes Trial (VADT), a multisite long-term study examining the effect of glucose control on cardiovascular (CV) complications in older patients with established, poorly controlled type 2 diabetes. Methods: We review the rationale, objectives, and design of the VADT and summarize the baseline data and the results achieved thus far. Results: The main objective of this 20-site, 1,792-patient study is to ascertain whether intensive glucose control can reduce major CV events in patients with difficult-to-control type 2 diabetes. The study design consists of a standard treatment arm and an intensive treatment arm, with a goal of 1.5% difference in hemoglobin A1c values between the two groups. The trial is now in its fifth year, with completion expected in December 2007. The planned glucose separation has been achieved and maintained to this point. Blood pressure and hemoglobin A1c levels have been reduced from baseline values, and established CV risk factors are within recommended ranges. Conclusion: The current results of the VADT show that excellent control of glucose and CV risk factors can be achieved and maintained in the population studied. The results of these interventions on CV outcomes will ultimately have important implications for the clinical care of older patients with advanced type 2 diabetes.

AB - Objective: To present a status report on the Veterans Affairs, Diabetes Trial (VADT), a multisite long-term study examining the effect of glucose control on cardiovascular (CV) complications in older patients with established, poorly controlled type 2 diabetes. Methods: We review the rationale, objectives, and design of the VADT and summarize the baseline data and the results achieved thus far. Results: The main objective of this 20-site, 1,792-patient study is to ascertain whether intensive glucose control can reduce major CV events in patients with difficult-to-control type 2 diabetes. The study design consists of a standard treatment arm and an intensive treatment arm, with a goal of 1.5% difference in hemoglobin A1c values between the two groups. The trial is now in its fifth year, with completion expected in December 2007. The planned glucose separation has been achieved and maintained to this point. Blood pressure and hemoglobin A1c levels have been reduced from baseline values, and established CV risk factors are within recommended ranges. Conclusion: The current results of the VADT show that excellent control of glucose and CV risk factors can be achieved and maintained in the population studied. The results of these interventions on CV outcomes will ultimately have important implications for the clinical care of older patients with advanced type 2 diabetes.

UR - http://www.scopus.com/inward/record.url?scp=33646564071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646564071&partnerID=8YFLogxK

M3 - Article

C2 - 16627388

AN - SCOPUS:33646564071

VL - 12

SP - 85

EP - 88

JO - Endocrine Practice

JF - Endocrine Practice

SN - 1530-891X

IS - SUPPL. 1

ER -